Navigation Links
Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Date:5/14/2009

Nektar Advanced Polymer Conjugate Technology Used in Cimzia(R) Through Exclusive Nektar-UCB Collaboration

SAN FRANCISCO, Calif., May 14 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) confirmed today UCB's announcement that the US Food and Drug Administration (FDA) has approved Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNFa (Tumor Necrosis Factor alpha), for the treatment of adult patients with moderately to severely active rheumatoid arthritis. Cimzia(R) utilizes Nektar's polymer conjugate technology through an exclusive Nektar-UCB collaboration.

It is estimated that 5 million people suffer from RA globally. In the United States alone, an estimated 1.3 million people have the disease. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.

Under the terms of the agreement between Nektar and UCB, Nektar receives manufacturing revenues during research, clinical development, and commercialization of Cimzia(R). Nektar also receives royalties on end product sales.

About Cimzia(R)

Cimzia(R) is the only PEGylated anti-TNF (Tumor Necrosis Factor). Cimzia(R) has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha. Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation. This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases. The U.S. Food and Drug Administration (FDA) has approved Cimzia(R) for reducing signs and symptoms of Crohn's disease and maintaining clinical response
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
2. Nektar to Announce Financial Results for the First Quarter of 2009 on Wednesday, May 6, 2009, After Close of U.S.-Based Financial Markets
3. Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics Announces Second Quarter 2008 Results
6. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
7. Nektar Therapeutics Announces First Quarter 2008 Results
8. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
9. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
10. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... A quality built chicken coop condo with a wheel ... to raise chickens on a pasture. By installing a wheel ... have a chicken tractor that stands up to being moved around ... it is able to flex to uneven ground without losing its ... are fertilized, and it will help provide the chickens with fresh ...
(Date:5/6/2015)... 06, 2015 Chesapeake Regional Medical ... of Virginia to acquire Intuitive Surgical, Inc.’s latest ... system upgrade includes enhanced surgical technique capabilities, which ... across a wide spectrum of specialties. Its advancements ... and quicker recovery times. , “As the only ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Is Colorado’s ... , Next month the Centennial State will mark the ... cannabis sales to adults. And while Colorado’s legal marijuana ... during that time, it’s also facing some new challenges. ... are currently facing shortages, especially in the wake of ...
(Date:5/6/2015)... Texas (PRWEB) May 06, 2015 vcfo, ... finance, HR, IT and operational support to optimize business ... Consulting CFOs, Jack Lynch and Michael Scheaffer. Both Lynch ... finance and leadership experience. , “We are delighted ... Ellen Wood, vcfo CEO. “Leveraging their background in financial ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2
... between ages 15 and 45. When a tumor is found, ... way it's removed, which often leaves men infertile, //can change ... all men who have testicular tumors in one testicle will ... they will have no hormonproduction and no possibility for fertility. ...
... fight another. Researchers say the little-known virus GBV-C, also ... a key to helping researchers devise new strategies against ... Multicenter Acquired Immunodeficiency Syndrome Cohort Study, in which investigators ... United States for more than 15 years. The study ...
... fluids may do more harm than good for patients ... previous studies to determine if recommending patients with respiratory ... shown during a respiratory infection, such as a cold ... specific hormone that conserves water. Thus, researchers say giving ...
... errors that occur in pediatric intensive care units are more ... more than 11,800 children who were admitted into pediatric intensive ... defined an error as any preventable event that may cause ... were reported during the course of the study. Nearly 70 ...
... can no longer be considered a benign condition or ... 60 percent of overweight children have at least one ... type 2 diabetes is increasing rapidly in developing countries ... 2 diabetes in developing countries has been attributed to ...
... or other painkillers that is characterized by the onset ... after taking the medications. British researchers analyzed more than ... percent of adults and about 5 percent of children ... these patients were also sensitive to over-the-counter non-steroidal anti-inflammatory ...
Cached Medicine News:Health News:Childhood Weight Gain Found To Increase The Risk of Diabetes 2
(Date:5/6/2015)... Saint-Gobain has acquired ZenPure, a ... products, mainly for the life sciences sector. ... a state-of-the-art plant in Hangzhou, China ... globe and will bolster the range of fluid systems ... is fully in line with the Group,s strategy of ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Global Suture Industry Report 2015" ... Global Suture Industry Report 2015 is a professional ... the suture industry. The report provides ... classifications, applications and industry chain structure. The suture ...
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is ... been reached to resolve lawsuits involving individuals who were ... - manufactured by Takeda Pharmaceuticals - has been associated ... of the firm,s attorneys were instrumental in the coordination ... Fibich - Founding Partner of Fibich, Leebron, Copeland, ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
... Dec. 9, 2011 /PRNewswire-iReach/ -- Novel Health ... the publication of  2010-2011 market trends study called ,What,s ... The published article is an analysis of sales, pricing, ... specialty biologic products. This study highlights several emerging trends ...
... FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2011 HeartWare ... HIN), a leading innovator of less invasive, miniaturized circulatory ... heart failure, today announced that CEO Doug Godshall is ... Conference at 10:50 a.m. EST on Wednesday, December 14, ...
Cached Medicine Technology:Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 2Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 3Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 4HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: